CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE - Generic Drug Details

What are the generic sources for calcium chloride; dextrose; potassium chloride; sodium chloride and what is the scope of freedom to operate?

Calcium chloride; dextrose; potassium chloride; sodium chloride is the generic ingredient in fourteen branded drugs marketed by Hospira, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Otsuka Icu Medcl, and Miles, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

US Patents:	0
Tradenames:	14
Applicants:	6
NDAs:	13
DailyMed Link:	CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE at DailyMed

Anatomical Therapeutic Chemical (ATC) Classes for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

A12AA	Calcium
A12A	CALCIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12BA	Potassium
A12B	POTASSIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

G04BA	Acidifiers
G04B	UROLOGICALS
G04	UROLOGICALS
G	Genito-urinary system and sex hormones

US Patents and Regulatory Information for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	211428-001	Nov 9, 2021		DISCN	No	No
Baxter Hlthcare	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	019367-006	Apr 5, 1985	AP	RX	No	No
Otsuka Icu Medcl	DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	017608-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	No
Hospira	DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018254-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Otsuka Icu Medcl	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	019685-004	Oct 17, 1988		DISCN	Yes	No
Baxter Hlthcare	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	019367-002	Apr 5, 1985		RX	No	No
Otsuka Icu Medcl	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	019685-001	Oct 17, 1988		DISCN	Yes	No

Market Overview and Financial Trajectory for Electrolyte Solutions (Calcium Chloride, Dextrose, Potassium Chloride, Sodium Chloride)

Last updated: February 13, 2026

---

What are the current market sizes and growth projections for electrolyte solutions?

Electrolyte solutions, including calcium chloride, dextrose, potassium chloride, and sodium chloride, primarily serve medical, industrial, and food processing markets. As of 2022, the global electrolyte solutions market was valued at approximately USD 8.5 billion. The compound annual growth rate (CAGR) is projected at 5.3% between 2023 and 2030, driven by increasing healthcare needs, aging populations, and food industry demand.

What are the key drivers influencing market dynamics?

1. Medical Use: Intravenous rehydration solutions constitute a significant portion of market revenue. Growing prevalence of dehydration, electrolyte imbalances, and chronic illnesses enhances demand. The global infusion therapy market is projected to reach USD 40 billion by 2025, with electrolyte solutions representing a major segment.

2. Food Industry Expansion: Sodium chloride (salt), potassium chloride, and dextrose are essential in food preservation and flavoring. The global food additive market forecasted to grow at 4.8% CAGR through 2026 supports increased consumption.

3. Industrial Applications: Calcium chloride and potassium chloride are used in de-icing, dust control, and water treatment. Climatic shifts impacting seasonal applications influence market volatility.

4. Regulatory and Supply Chain Factors: Stringent FDA and EPA regulations impact manufacturing practices. Raw material availability and geopolitical factors affect supply stability and pricing.

What are revenue contributions and pricing trends for each compound?

Compound	Primary Markets	Estimated Global Market Size (2022)	Pricing Trends	Key Factors Affecting Price
Calcium chloride	Medical, industrial, food	USD 1.2 billion	Stable, slight increase	Raw material costs, demand in de-icing, regulatory compliance
Dextrose	Medical, food, pharma	USD 2.7 billion	Slight decline	Commodity pricing, supply of corn-based glucose
Potassium chloride	Medical, agriculture, food	USD 2.0 billion	Rising modestly	Agricultural demand, crop yields, fertilizer markets
Sodium chloride	Medical, industrial, food	USD 2.6 billion	Stable	Food demand fluctuations, industrial use cycles

What are the competitive landscape and key players?

Major companies include Novartis (glucose solutions), BASF, Otsuka Pharmaceutical, and AkzoNobel. These firms invest heavily in manufacturing capacity and R&D to improve purity and delivery systems, while supply chain efficiencies underpin pricing.

What is the potential impact of emerging trends?

• Generic Market Penetration: Increased uptake of generic electrolyte solutions may pressure prices.
• Biotechnology R&D: Development of novel electrolyte formulations for targeted therapies could open new markets.
• Sustainability Initiatives: Use of sustainable raw materials and environmentally friendly production processes can influence costs and market positioning.

---

Key financial considerations:

• Margins for electrolyte solutions are generally low to moderate, ranging from 8% to 15%, due to commodity nature and intense competition.
• Capital investments in manufacturing plants require USD 50-200 million, depending on scale.
• Regulatory compliance costs are rising, especially for intravenous and food-grade products.
• Pricing consistency remains challenged by raw material price fluctuations, notably in potassium and sodium sources.

---

What are future market and revenue forecasts?

The electrolyte solutions market is expected to exceed USD 14 billion by 2030. The medical sector—mainly infusion therapy—will sustain the highest growth. Industrial and food segments will contribute steadily, driven by regulatory stabilization and expanding end-use applications.

---

Summary of supply risks and price volatility

Risk Factors	Impact	Mitigation Strategies
Raw material shortages	Price spikes, supply delays	Long-term supply agreements, alternative sourcing
Regulatory changes	Production restrictions, costs rise	Compliance investment, product diversification
Geopolitical tensions	Disruption in supply chains	Diversified manufacturing bases, inventory buffers

---

Key Takeaways

• The global electrolyte solutions market is geographically broad, with rapid growth in Asia-Pacific and North America.
• Medical uses dominate revenue, especially infusion solutions.
• Industrial and food markets provide stable but slower growth channels.
• Pricing remains sensitive to raw material costs and regulatory environments.
• Investment in sustainability and innovative formulations could open new revenue streams.

---

FAQs

1. Which electrolyte compound has the highest market growth?
Potassium chloride is expected to see the highest CAGR (~6%) driven mainly by agriculture and medical demand.

2. How do raw material prices affect the market?
Fluctuations directly impact manufacturing costs and pricing stability, leading to cyclical price adjustments.

3. What regulatory hurdles exist for electrolyte solutions?
FDA and EPA standards govern manufacturing practices, labeling, and safety testing, adding compliance costs.

4. Are new formulations emerging in this market?
Yes, especially in biotech, with developments in targeted electrolyte delivery for specialized therapies.

5. How does geographic variation influence supply and pricing?
Supply chain risks are higher in regions with political instability or raw material shortages, affecting prices and availability.

---

Sources

[1] MarketWatch, "Global Electrolyte Solutions Market," 2022.
[2] Grand View Research, "Infusion Therapy Market Size, Share & Trends," 2023.
[3] Mordor Intelligence, "Food Additives Market Outlook," 2022.
[4] Transparency Market Research, "Industrial Salt Market," 2023.